Top Markets
#1 Pleasing Gold Pleasing Gold +1,496.37%
#2 PulseChain PulseChain +58.12%
#3 Ontology Gas Ontology Gas +37.96%
#4 Merlin's Seal BTC Merlin's Seal BTC +33.44%
#5 BOOK OF MEME BOOK OF MEME +30.66%
#6 Unit Pump Unit Pump +25.83%
#7 Pump.fun Pump.fun +25.83%
#8 Neiro Neiro +25.36%
#9 ConstitutionDAO ConstitutionDAO +23.34%
#10 Collect on Fanable Collect on Fanable +23.27%
Coin of the day
Pleasing Gold Pleasing Gold
設定
言語
日本
通貨
USD
テーマ
Molecure S.A. Molecure S.A.

Molecure S.A.

MOC
株式のランク #26169
Operating as a biopharmaceutical firm in Poland, Molecure S.A. specializes in... Operating as a biopharmaceutical firm in Poland, Molecure S.A. specializes in the research, development, and commercialization of innovative therapies designed to combat neoplastic (cancer) and inflammatory conditions. The company's pipeline prominently features OATD-01, a chitotriosidase/acidic mammalian chitinase inhibitor that has successfully advanced through Phase I clinical trials for the treatment of idiopathic pulmonary fibrosis and sarcoidosis. Additionally, Molecure is progressing its YKL-40 program for cancer and fibrosis, OATD-02 for oncology applications, and a Deubiquitinase program. Established in 2012, this Warsaw-headquartered enterprise adopted the name Molecure S.A. in March 2022, having previously been known as OncoArendi Therapeutics S.A.
株価
$1.73
時価総額
$42.88M
変化（1日）
2.16%
変化（1年）
-18.85%
国
PL
取引 Molecure S.A. (MOC)

カテゴリー

Healthcare
Molecure S.A.（MOC）の株価履歴
終値の最高値: $1.72 （2026-08-01）

終値の最安値: $8.01 （2018-04-01）
Molecure S.A. の株価履歴（2018 ～ 2026）
年間株価パフォーマンス
年 パフォーマンス
2026 (TTM) -4.92%
2025 -23.76%
2024 -51.57%
2023 52.92%
2022 -63.44%
2021 -31.76%
2020 420.16%
2019 -41.51%
2018 0.00%
類似企業または競合の株価
企業 株価 変化率 1年% 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $539.96 36.92%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.03K 56.34%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $120.74 -14.98%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $761.87 7.04%
CH
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $133.41 396.11%
US